These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12113190)

  • 21. An unusual case of neonatal anuria.
    Prasad N; Gulati S; Jain M; Tewari P
    Indian Pediatr; 2003 Mar; 40(3):258-60. PubMed ID: 12657763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors.
    Piper JM; Ray WA; Rosa FW
    Obstet Gynecol; 1992 Sep; 80(3 Pt 1):429-32. PubMed ID: 1495700
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin converting enzyme inhibitors in pregnancy.
    Mastrobattista JM
    Semin Perinatol; 1997 Apr; 21(2):124-34. PubMed ID: 9201818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversible oligohydramnios in a pregnancy with angiotensin-converting enzyme inhibitor exposure.
    Chisholm CA; Chescheir NC; Kennedy M
    Am J Perinatol; 1997 Oct; 14(9):511-3. PubMed ID: 9394157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessing the teratogenic potential of angiotensin-converting enzyme inhibitors in pregnancy.
    Burrows RF; Burrows EA
    Aust N Z J Obstet Gynaecol; 1998 Aug; 38(3):306-11. PubMed ID: 9761159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Taking ACE inhibitors during early pregnancy: is it safe?
    Ray JG; Vermeulen MJ; Koren G
    Can Fam Physician; 2007 Sep; 53(9):1439-40. PubMed ID: 17872870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are angiotensin-converting enzyme inhibitors and angiotensin receptor blockers safe in pregnancy: a report of ninety-one pregnancies.
    Karthikeyan VJ; Ferner RE; Baghdadi S; Lane DA; Lip GY; Beevers DG
    J Hypertens; 2011 Feb; 29(2):396-9. PubMed ID: 21119533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fetal and neonatal effects of treatment with angiotensin-converting enzyme inhibitors in pregnancy.
    Hanssens M; Keirse MJ; Vankelecom F; Van Assche FA
    Obstet Gynecol; 1991 Jul; 78(1):128-35. PubMed ID: 2047053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adverse reactions to drugs: angiotensin-converting enzyme inhibitors and pregnancy.
    Birbari AE
    J Med Liban; 1993; 41(2):99. PubMed ID: 8057352
    [No Abstract]   [Full Text] [Related]  

  • 30. Angiotensin-converting enzyme inhibitors during pregnancy: a survey of 22 patients given captopril and nine given enalapril.
    Kreft-Jais C; Plouin PF; Tchobroutsky C; Boutroy MJ
    Br J Obstet Gynaecol; 1988 Apr; 95(4):420-2. PubMed ID: 2838069
    [No Abstract]   [Full Text] [Related]  

  • 31. Exposure to angiotensin-converting enzyme inhibitors during first trimester: is it safe to fetus?
    Yip SK; Leung TN; Fung HY
    Acta Obstet Gynecol Scand; 1998 May; 77(5):570-1. PubMed ID: 9654182
    [No Abstract]   [Full Text] [Related]  

  • 32. ACE inhibitors and congenital anomalies.
    Friedman JM
    N Engl J Med; 2006 Jun; 354(23):2498-500. PubMed ID: 16760451
    [No Abstract]   [Full Text] [Related]  

  • 33. [Teratogenic effects of ACE-inhibitors and angiotensin II receptor antagonists].
    Sørensen AM; Christensen S; Jonassen TE; Andersen D; Petersen JS
    Ugeskr Laeger; 1998 Mar; 160(10):1460-4. PubMed ID: 9520613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hypertension in pregnancy. ACE inhibitors and angiotensin II receptor antagonists are contraindicated because of their potential fetotoxicity].
    Partosch F; Stahlmann R
    Med Monatsschr Pharm; 2011 Oct; 34(10):358-62. PubMed ID: 22010419
    [No Abstract]   [Full Text] [Related]  

  • 35. Neonatal acute renal failure secondary to maternal exposure to telmisartan, angiotensin II receptor antagonist.
    Pietrement C; Malot L; Santerne B; Roussel B; Motte J; Morville P
    J Perinatol; 2003; 23(3):254-5. PubMed ID: 12732865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fetal and neonatal consequences of antenatal exposure to type 1 angiotensin II receptor-antagonists.
    Vendemmia M; Garcia-Méric P; Rizzotti A; Boubred F; Lacroze V; Liprandi A; Simeoni U
    J Matern Fetal Neonatal Med; 2005 Aug; 18(2):137-40. PubMed ID: 16203601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiotensin converting enzyme inhibitor fetopathy.
    Hegde AU; Parekji S; Ali US; Mehta KP
    Indian Pediatr; 1999 Jan; 36(1):79-82. PubMed ID: 10709127
    [No Abstract]   [Full Text] [Related]  

  • 38. A 14-year-old girl with renal abnormalities after brief intrauterine exposure to enalapril during late gestation.
    Guron G; Mölne J; Swerkersson S; Friberg P; Hansson S
    Nephrol Dial Transplant; 2006 Feb; 21(2):522-5. PubMed ID: 16311256
    [No Abstract]   [Full Text] [Related]  

  • 39. [Fetal angiotensin converting enzyme (ACE) inhibition renal failure].
    Muto R; Ohashi H
    Ryoikibetsu Shokogun Shirizu; 2001; (33):678-9. PubMed ID: 11462629
    [No Abstract]   [Full Text] [Related]  

  • 40. Angiotensin-converting enzyme inhibitor fetopathy: long-term outcome.
    Laube GF; Kemper MJ; Schubiger G; Neuhaus TJ
    Arch Dis Child Fetal Neonatal Ed; 2007 Sep; 92(5):F402-3. PubMed ID: 17284475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.